Focal Encephalopathy Following Methotrexate Therapy
- 1 July 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 38 (7), 450-452
- https://doi.org/10.1001/archneur.1981.00510070084016
Abstract
• Two patients with lymphoreticular malignant neoplasms and leptomeningeal tumor spread were treated with intraventricular administration of methotrexate via an Ommaya reservoir. The intraventricular instillation of methotrexate resulted in focal CNS damage in brain parenchyma inadvertently pierced by the shunt. Disorientation, aphasia, and right hemiparesis developed in both patients. Computed tomography disclosed a contrast-enhancing, low-density mass in the left cerebral cortex where the distal shunt tip was lodged. In one case the lesion was pathologically consistent with chronic inflammation. A lesion occurred in one patient despite repositioning of the shunt prior to methotrexate instillation. Shunt removal and administration of systemic corticosteroids resulted in resolution of symptoms in one patient.This publication has 7 references indexed in Scilit:
- Intraventricular versus intralumbar methotrexate for central‐nervous‐system leukemia: Prolonged remission with the ommaya reservoirMedical and Pediatric Oncology, 1979
- The ommaya reservoir.Newly recognized complications and recommendations for insertion and useCancer, 1978
- Computed Tomographic Appearance of Methotrexate-Induced Necrotizing LeukoencephalopathyRadiology, 1977
- COMBINATION INTRATHECAL THERAPY FOR MENINGEAL LEUKEMIA - 2 VERSUS 3 DRUGS1977
- COMBINATION CHEMOTHERAPY (CHOP-BLEO) IN ADVANCED (NON-HODGKIN) MALIGNANT-LYMPHOMA1977
- Reservoirs for Intraventricular ChemotherapyNew England Journal of Medicine, 1973
- The increasing incidence of central nervous system leukemia in children.(Children's cancer study group a)Cancer, 1970